Epstein-Barr virus Fields Virology, Lippincot-Raven, pp.2397-2446, 1996. ,
Epstein Barr virus-associated tumours: an update for the attention of the working pathologist, Journal of Clinical Pathology, vol.60, issue.12, pp.1358-1364, 2007. ,
DOI : 10.1136/jcp.2006.044586
Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma, Cancer Investigation, vol.92, issue.4, pp.401-406, 2008. ,
DOI : 10.1056/NEJM199811193392104
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, Annals of Oncology, vol.11, issue.suppl 1, pp.113-116, 2000. ,
DOI : 10.1093/annonc/11.suppl_1.S113
Oncolytic Potential of Rodent Parvoviruses for Cancer Therapy in Humans: A Brief Review, Journal of Veterinary Medicine Series B, vol.91, issue.7-8, pp.327-330, 2005. ,
DOI : 10.1093/jnci/93.12.903
Cyclin A activates the DNA polymerase delta -dependent elongation machinery in vitro: A parvovirus DNA replication model, Proceedings of the National Academy of Sciences, vol.97, issue.10, pp.5522-5527, 2000. ,
DOI : 10.1073/pnas.090485297
Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells, J Virol, vol.69, pp.5506-5515, 1995. ,
The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression, J Virol, vol.68, pp.6446-6453, 1994. ,
Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins, EMBO J, vol.9, pp.2989-2995, 1990. ,
Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway, J Virol, vol.72, pp.8893-8903, 1998. ,
Parvovirus H-1-induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis, Virus Research, vol.65, issue.2, pp.161-174, 1999. ,
DOI : 10.1016/S0168-1702(99)00115-X
Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors, Cancer Gene Therapy, vol.8, issue.3, pp.158-167, 2001. ,
DOI : 10.1038/sj.cgt.7700288
Cytosolic Activation of Cathepsins Mediates Parvovirus H-1-Induced Killing of Cisplatin and TRAIL-Resistant Glioma Cells, Journal of Virology, vol.81, issue.8, pp.4186-4198, 2007. ,
DOI : 10.1128/JVI.02601-06
Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection, International Journal of Cancer, vol.66, issue.4, pp.584-589, 1998. ,
DOI : 10.1002/(SICI)1097-0215(19980209)75:4<584::AID-IJC15>3.0.CO;2-9
Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells, Cancer Res, vol.49, pp.3203-3208, 1989. ,
Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV, Clinical Cancer Research, vol.15, issue.2, pp.511-519, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1088
URL : https://hal.archives-ouvertes.fr/pasteur-00748222
Antineoplasic activity of parvoviruses, Journal of Virological Methods, vol.33, issue.3, pp.233-251, 1991. ,
DOI : 10.1016/0166-0934(91)90024-T
Transformation of human cells by oncogenic viruses supports permissiveness for parvovirus H-1 propagation, J Virol, vol.63, pp.2152-2158, 1989. ,
Persistence of parvovirus H-1 DNA in human B- and T-lymphoma cells, Virus Research, vol.16, issue.2, pp.211-223, 1990. ,
DOI : 10.1016/0168-1702(90)90024-6
Lymphoma and reticuloendothelial neoplasms Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of, National Cancer Institute, pp.1972-2000, 2006. ,
Biology and Treatment of Epstein-Barr Virus-Associated Non-Hodgkin Lymphomas, Hematology, vol.2005, issue.1, pp.260-266, 2005. ,
DOI : 10.1182/asheducation-2005.1.260
MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells, International Journal of Cancer, vol.170, issue.6, pp.1364-1371, 2007. ,
DOI : 10.1002/ijc.22421
Targeting Human Glioblastoma Cells: Comparison of Nine Viruses with Oncolytic Potential, Journal of Virology, vol.79, issue.10, pp.6005-6022, 2005. ,
DOI : 10.1128/JVI.79.10.6005-6022.2005
Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin, Blood, vol.97, issue.5, pp.1392-1398, 2001. ,
DOI : 10.1182/blood.V97.5.1392
A model for tumor suppression using H-1 parvovirus., Proceedings of the National Academy of Sciences, vol.90, issue.18, pp.8702-8706, 1993. ,
DOI : 10.1073/pnas.90.18.8702
p53 is frequently mutated in Burkitt's lymphoma cell lines, EMBO J, vol.10, pp.2879-2887, 1991. ,
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma, New England Journal of Medicine, vol.337, issue.8, pp.529-534, 1997. ,
DOI : 10.1056/NEJM199708213370804
The non-structural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2, Cell Growth Differ, vol.6, pp.781-787, 1995. ,
Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6, J Virol, vol.67, pp.6768-6777, 1993. ,
Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus, BMC Microbiology, vol.2, issue.1, p.20, 2002. ,
DOI : 10.1186/1471-2180-2-20
Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro., Proceedings of the National Academy of Sciences, vol.80, issue.7, pp.1987-1991, 1983. ,
DOI : 10.1073/pnas.80.7.1987
Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects, Leukemia, vol.12, issue.12, pp.2029-2033, 1998. ,
DOI : 10.1038/sj.leu.2401236
Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis, Leukemia, vol.9, issue.2, pp.361-369, 2008. ,
DOI : 10.1158/0008-5472.CAN-06-0577
Ras signalling as a marker for application of oncolytic herpes mutant against lymphoma, Mol Ther, vol.9, p.26, 2004. ,
Reovirus therapy of lymphoid malignancies, Blood, vol.100, issue.12, pp.4146-4153, 2002. ,
DOI : 10.1182/blood-2002-02-0503
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice, Blood, vol.97, issue.12, pp.3746-3754, 2001. ,
DOI : 10.1182/blood.V97.12.3746
CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA), The Lancet, vol.283, issue.7327, pp.238-240, 1964. ,
DOI : 10.1016/S0140-6736(64)92345-1
Distinctions between endemic and sporadic forms of epstein-barr virus-positive burkitt's lymphoma, International Journal of Cancer, vol.417, issue.4, pp.435-441, 1985. ,
DOI : 10.1002/ijc.2910350404
An EBVgenome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection, Intervirology, vol.5, pp.319-334, 1975. ,
An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA, Virus Genes, vol.76, issue.2, pp.147-156, 1991. ,
DOI : 10.1007/BF00571929
Cytogenetic investigations in Hodgkin's disease: I. Involvement of specific chromosomes in marker formation, Cancer Genetics and Cytogenetics, vol.20, issue.1-2, pp.39-52, 1986. ,
DOI : 10.1016/0165-4608(86)90106-8
A Hodgkin???s Disease Cell Line, KM-H2, Shows Biphenotypic Features of Dendritic Cells and B Cells, International Journal of Hematology, vol.94, issue.2, pp.236-244, 2001. ,
DOI : 10.1007/BF02981944
Hodgkin's disease derived cell lines HDLM-2 and L-428: Comparison of morphology, immunological and isoenzyme profiles, Leukemia Research, vol.10, issue.5, pp.487-500, 1986. ,
DOI : 10.1016/0145-2126(86)90084-6
Chimeric and Pseudotyped Parvoviruses Minimize the Contamination of Recombinant Stocks with Replication-Competent Viruses and Identify a DNA Sequence That Restricts Parvovirus H-1 in Mouse Cells, Journal of Virology, vol.77, issue.6, pp.3851-3858, 2003. ,
DOI : 10.1128/JVI.77.6.3851-3858.2003
Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice, Cancer Gene Therapy, vol.9, issue.5, pp.432-442, 2002. ,
DOI : 10.1038/sj.cgt.7700457
Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein, J Virol, vol.68, pp.1397-1406, 1994. ,